DBVT Stock Analysis: Buy, Sell, or Hold?

DBVT - DBV Technologies S.A.

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$21.61
-1.35 (-5.88%) ▼
WAIT
LOW Confidence
Protect Your DBVT Gains
Last Updated: January 30, 2026

Get Alerted When DBVT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: DBVT is down 11.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: DBVT is currently trading at $21.61, which is considered slightly high relative to its 30-day fair value range of $17.50 to $22.32.

Technical Outlook: Technically, DBVT is in a strong uptrend. Immediate support is located at $19.76, while resistance sits at $25.40. Short-term momentum is weak, with the stock down 5.9% recently.

Market Sentiment: DBVT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $40.82 (+77.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $17.50 - $22.32
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 73.7%

Protect Your Profits

Holding DBVT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-5.9%)
  • BULLISH: Trading 77.8% below Wall St target ($40.82)
  • WARNING: Recommendation downgraded due to -11.9% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $17.50 - $22.32
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $19.76
Resistance Level $25.40
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -49.54
Wall Street Target $40.82 (+77.8%)
Revenue Growth (YoY) 158.8%
Last updated: January 30, 2026 7:30 PM ET
Data refreshes hourly during market hours. Next update: 8:30 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$500 62 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$91 64 BUY
INSM
Insmed Inc
STRONG BUY
19 analysts
$214 60 BUY
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$830 52 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$216 53 HOLD

Advanced DBVT Option Strategies

Professional options setups generated by AI based on today's DBVT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for DBVT

DBVT Technical Chart DBVT Price Prediction DBVT Investment Advisor DBVT Fair Price Analyzer DBVT Options Advisor DBVT Options Chain DBVT Options Analysis DBVT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals